Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Labiano

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Oncoimmunology|June 23, 2017
Cellular immunotherapies for cancerPedro Berraondo, Sara Labiano, Luna Minute, et al.
Methods in Cell Biology|March 31, 2024
Radiotherapy protocols for mouse cancer modelEneko Garate-Soraluze, Javier Marco-Sanz, Irantzu Serrano-Mendioroz, et al.
Genes & Cancer|September 9, 2011
LIF, a Novel STAT5-Regulated Gene, Is Aberrantly Expressed in Myeloproliferative NeoplasmsElisa M Salas, María J García-Barchino, Sara Labiano, et al.
Cancer Immunology Research|February 19, 2015
Virotherapy with a Semliki Forest Virus-Based Vector Encoding IL12 Synergizes with PD-1/PD-L1 BlockadeJosé I Quetglas, Sara Labiano, M Ángela Aznar, et al.
European Journal of Immunology|January 17, 2016
Deciphering CD137 (4-1BB) signaling in T-cell costimulation for translation into successful cancer immunotherapyAlfonso R Sanchez-Paulete, Sara Labiano, Maria E Rodriguez-Ruiz, et al.
Cancer Immunology Research|November 15, 2017
CD137 (4-1BB) Costimulation Modifies DNA Methylation in CD8<sup>+</sup> T Cell-Relevant GenesM Angela Aznar, Sara Labiano, Angel Diaz-Lagares, et al.
Cancer Immunology Research|April 22, 2018
Mitochondrial Morphological and Functional Reprogramming Following CD137 (4-1BB) CostimulationAlvaro Teijeira, Sara Labiano, Saray Garasa, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 3, 2015
Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAbBettina Weigelin, Elixabet Bolaños, Alvaro Teijeira, et al.
Molecular Therapy Oncolytics|February 12, 2021
Local administration of IL-12 with an HC vector results in local and metastatic tumor control in pediatric osteosarcomaMarta Zalacain, María Bunuales, Lucía Marrodan, et al.
Cancer Discovery|October 24, 2015
Cancer Immunotherapy with Immunomodulatory Anti-CD137 and Anti-PD-1 Monoclonal Antibodies Requires BATF3-Dependent Dendritic CellsAlfonso R Sánchez-Paulete, Francisco J Cueto, María Martínez-López, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Oncoimmunology|June 23, 2017
Cellular immunotherapies for cancerPedro Berraondo, Sara Labiano, Luna Minute, et al.
Methods in Cell Biology|March 31, 2024
Radiotherapy protocols for mouse cancer modelEneko Garate-Soraluze, Javier Marco-Sanz, Irantzu Serrano-Mendioroz, et al.
Genes & Cancer|September 9, 2011
LIF, a Novel STAT5-Regulated Gene, Is Aberrantly Expressed in Myeloproliferative NeoplasmsElisa M Salas, María J García-Barchino, Sara Labiano, et al.
Cancer Immunology Research|February 19, 2015
Virotherapy with a Semliki Forest Virus-Based Vector Encoding IL12 Synergizes with PD-1/PD-L1 BlockadeJosé I Quetglas, Sara Labiano, M Ángela Aznar, et al.
European Journal of Immunology|January 17, 2016
Deciphering CD137 (4-1BB) signaling in T-cell costimulation for translation into successful cancer immunotherapyAlfonso R Sanchez-Paulete, Sara Labiano, Maria E Rodriguez-Ruiz, et al.
Cancer Immunology Research|November 15, 2017
CD137 (4-1BB) Costimulation Modifies DNA Methylation in CD8<sup>+</sup> T Cell-Relevant GenesM Angela Aznar, Sara Labiano, Angel Diaz-Lagares, et al.
Cancer Immunology Research|April 22, 2018
Mitochondrial Morphological and Functional Reprogramming Following CD137 (4-1BB) CostimulationAlvaro Teijeira, Sara Labiano, Saray Garasa, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 3, 2015
Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAbBettina Weigelin, Elixabet Bolaños, Alvaro Teijeira, et al.
Molecular Therapy Oncolytics|February 12, 2021
Local administration of IL-12 with an HC vector results in local and metastatic tumor control in pediatric osteosarcomaMarta Zalacain, María Bunuales, Lucía Marrodan, et al.
Cancer Discovery|October 24, 2015
Cancer Immunotherapy with Immunomodulatory Anti-CD137 and Anti-PD-1 Monoclonal Antibodies Requires BATF3-Dependent Dendritic CellsAlfonso R Sánchez-Paulete, Francisco J Cueto, María Martínez-López, et al.
Pageof 5